Barely Significant
← all excerpts

Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options.

Blood · 2021 · PMC8703362 · PMID 33945616

Europe PMCDOI
1
hedged sentence
0.0810
closest p · 1.6× alpha
0.0810
boldest claim

The sentences

showed a trendP = .081so close (0.05 < p ≤ 0.1)
The difference from TP53 -wt was statistically significant in the subgroup carrying mutations <1% VAF ( P = .0018) and showed a trend for mutations that were 1% to 10% VAF ( P = .081; Figure 2D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.